Effectiveness & Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in

See also
Status	Clinical Trial	Phase
Completed	`NCT00994760` - Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years	N/A
Completed	`NCT01842893` - Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer	Phase 3
Completed	`NCT02886286` - Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain	Phase 4
Completed	`NCT02869321` - Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy	Phase 4
Completed	`NCT02840500` - Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units	N/A
Completed	`NCT02437929` - Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment	N/A
Completed	`NCT00236145` - Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain	Phase 3
Completed	`NCT02836379` - Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent	N/A
Active, not recruiting	`NCT02278601` - Comparison of Regimens MPIB, CIPCEA, PCEA	Phase 3
Terminated	`NCT00842829` - Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients	Phase 4
Recruiting	`NCT05200806` - A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy	Phase 4
Withdrawn	`NCT03809455` - Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients	Phase 2
Completed	`NCT03435120` - Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)
Completed	`NCT02050503` - Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis	N/A
Terminated	`NCT00387010` - Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain	Phase 3
Withdrawn	`NCT05053308` - Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement	N/A
Recruiting	`NCT04011150` - Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour	Phase 3
Terminated	`NCT01901718` - An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.	N/A
Completed	`NCT00402350` - Staccato Fentanyl Single and Multidose PK	Phase 1
Completed	`NCT00236041` - Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)	Phase 2

NCT number	NCT05531422
Study type	Interventional
Source	Lee's Pharmaceutical Limited
Contact
Status	Not yet recruiting
Phase	Phase 2
Start date	September 20, 2022
Completion date	May 20, 2023

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms